Similar articles

• Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation.

  Poçi D, Hartford M, Karlsson T, Herlitz J, Edvardsson N, Caidahl K. Poçi D, et al. Chest. 2012 Jun;141(6):1431-1440. doi: 10.1378/chest.11-0435. Epub 2011 Oct 20. Chest. 2012. PMID: 22016485
• Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.

  Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB; APPROACH investigators. Mitchell LB, et al. Heart. 2014 Oct;100(19):1524-30. doi: 10.1136/heartjnl-2013-305303. Epub 2014 May 23. Heart. 2014. PMID: 24860007
• The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.

  Morillas P, Pallarés V, Fácila L, Llisterri JL, Sebastián ME, Gómez M, Castilla E, Camarasa R, Sandin M, García-Honrubia A; FAPRES registry investigators. Morillas P, et al. Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):485-91. doi: 10.1016/j.rec.2014.06.027. Epub 2014 Dec 2. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25487320
• Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome.

  Ice DS, Shapiro TA, Gnall EM, Kowey PR. Ice DS, et al. Am J Cardiol. 2014 Mar 1;113(5):888-96. doi: 10.1016/j.amjcard.2013.11.046. Epub 2013 Dec 12. Am J Cardiol. 2014. PMID: 24528617 Review.
• The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.

  Reddy P, Giugliano RP. Reddy P, et al. J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):526-32. doi: 10.1177/1074248414525505. Epub 2014 Mar 21. J Cardiovasc Pharmacol Ther. 2014. PMID: 24659084 Review.